A. Flamier

694 total citations
8 papers, 630 citations indexed

About

A. Flamier is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Biochemistry. According to data from OpenAlex, A. Flamier has authored 8 papers receiving a total of 630 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 4 papers in Cellular and Molecular Neuroscience and 2 papers in Biochemistry. Recurrent topics in A. Flamier's work include Neuroscience and Neuropharmacology Research (4 papers), Receptor Mechanisms and Signaling (4 papers) and Amino Acid Enzymes and Metabolism (2 papers). A. Flamier is often cited by papers focused on Neuroscience and Neuropharmacology Research (4 papers), Receptor Mechanisms and Signaling (4 papers) and Amino Acid Enzymes and Metabolism (2 papers). A. Flamier collaborates with scholars based in France. A. Flamier's co-authors include A. Uzan, G. Le Fur, Jesús Bénavidès, C. Guérémy, M.C. Dubroeucq, C. Renault, F. Imbault, Ugo Testa, P Thomopoulos and Marie‐Claude Burgevin and has published in prestigious journals such as Diabetes, Life Sciences and Neuropharmacology.

In The Last Decade

A. Flamier

8 papers receiving 587 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
A. Flamier France 7 396 352 76 62 62 8 630
André Uzan France 19 338 0.9× 371 1.1× 65 0.9× 43 0.7× 68 1.1× 34 815
F. Imbault France 6 529 1.3× 345 1.0× 78 1.0× 66 1.1× 75 1.2× 8 805
Dominique Quarteronet France 8 426 1.1× 306 0.9× 64 0.8× 25 0.4× 36 0.6× 10 563
Kazuyuki Tomisawa Japan 15 271 0.7× 317 0.9× 111 1.5× 60 1.0× 130 2.1× 51 846
Bruce A. Donzanti United States 10 512 1.3× 366 1.0× 106 1.4× 77 1.2× 31 0.5× 19 934
P.-A. Löschmann Germany 12 287 0.7× 294 0.8× 94 1.2× 56 0.9× 38 0.6× 19 822
Hervé Ansanay France 15 400 1.0× 520 1.5× 47 0.6× 53 0.9× 66 1.1× 17 760
D. E. BRUNDISH Switzerland 9 315 0.8× 295 0.8× 49 0.6× 36 0.6× 47 0.8× 16 479
Jean‐Marc Kamenka France 16 792 2.0× 635 1.8× 53 0.7× 29 0.5× 93 1.5× 41 1.1k
Kazuo Koshiya Japan 14 343 0.9× 245 0.7× 46 0.6× 49 0.8× 38 0.6× 25 509

Countries citing papers authored by A. Flamier

Since Specialization
Citations

This map shows the geographic impact of A. Flamier's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. Flamier with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. Flamier more than expected).

Fields of papers citing papers by A. Flamier

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A. Flamier. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. Flamier. The network helps show where A. Flamier may publish in the future.

Co-authorship network of co-authors of A. Flamier

This figure shows the co-authorship network connecting the top 25 collaborators of A. Flamier. A scholar is included among the top collaborators of A. Flamier based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A. Flamier. A. Flamier is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Bénavidès, Jesús, C. Malgouris, A. Flamier, et al.. (1984). Biochemical evidence that 2-phenyl-4[2-(4-piperidinyl) ethyl]quinoline, a quinoline derivative with pure anticonflict properties, is a partial agonist of benzodiazepine receptors. Neuropharmacology. 23(10). 1129–1136. 13 indexed citations
2.
Fur, G. Le, F. Imbault, A. Flamier, et al.. (1983). Peripheral benzodiazepine binding sites: Effect of PK 11195, 1-(2-chlorophenyl)-n-methyl-n-(1-methylpropyl)-3-isoquinolinecarboxamide. Life Sciences. 32(16). 1839–1847. 316 indexed citations
3.
Fur, G. Le, A. Flamier, Jesús Bénavidès, et al.. (1983). Differentiation between two ligands for peripheral benzodiazepine binding sites, [3H]R05-4864 and [3H]PK 11195, by thermodynamic studies. Life Sciences. 33(5). 449–457. 240 indexed citations
4.
Perrot, Jean‐Yves, Claude Boucheix, A. Flamier, et al.. (1983). Detection of binding sites for spiroperidol on leukemic cells: Its value for the phenotype characterization of lymphoid leukemias. Leukemia Research. 7(3). 349–355. 3 indexed citations
5.
Fur, G. Le, et al.. (1983). A subacute treatment of L-methionine induces an increase in the number of [3H]spiperone binding sites in the striatum of the rat. Life Sciences. 32(20). 2321–2328. 7 indexed citations
6.
Fur, G. Le, E. Zarifian, A. Flamier, et al.. (1983). [3H]spiroperidol binding on lymphocytes : Changes in two different groups of schizophrenic patients and effect of neuroleptic treatment. Life Sciences. 32(3). 249–255. 28 indexed citations
7.
Flamier, A., et al.. (1982). [L-Methionine treatment of Parkinson's disease: preliminary results].. PubMed. 138(4). 297–303. 6 indexed citations
8.
Thomopoulos, P, et al.. (1980). Insulin Receptors and Protein Synthesis in Bone Marrow Cells and Reticulocytes. Diabetes. 29(10). 820–824. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026